PROTAC ER Degrader-2 serves as a synthesis intermediate for the production of PAC, a compound that incorporates the ADCs linker and PROTACs, which are subsequently conjugated to an antibody. PAC, exhibits a greater capability to degrade estrogen receptor-alpha (ERalpha) compared to PROTAC (without the presence of an antibody)[1].
Molekulargewicht:
1581.85
Formel:
C89H104N12O15
Target-Kategorie:
Estrogen Receptor/ERR|||PROTACs|||Others
T18606
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
